ČULEN, Martin, Daniel BUŠA, Zdeňka HERUDKOVÁ, Jan HÝL, Jakub VLAŽNÝ, Květoslava MATULOVÁ, Martin REPKO, Lucy VOJTOVÁ and Jiří MAYER. AML engraftment in humanized ossicles is not governed by biomaterial selection. In ESH: 4th Scientific Workshop: the Haematological Tumour Microenvironment and its Therapeutic Targeting, UK, Londýn. 2023.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name AML engraftment in humanized ossicles is not governed by biomaterial selection.
Authors ČULEN, Martin (703 Slovakia, belonging to the institution), Daniel BUŠA (703 Slovakia, belonging to the institution), Zdeňka HERUDKOVÁ (203 Czech Republic), Jan HÝL (203 Czech Republic, belonging to the institution), Jakub VLAŽNÝ (203 Czech Republic, belonging to the institution), Květoslava MATULOVÁ (203 Czech Republic, belonging to the institution), Martin REPKO (203 Czech Republic, belonging to the institution), Lucy VOJTOVÁ (203 Czech Republic) and Jiří MAYER (203 Czech Republic, guarantor, belonging to the institution).
Edition ESH: 4th Scientific Workshop: the Haematological Tumour Microenvironment and its Therapeutic Targeting, UK, Londýn, 2023.
Other information
Original language English
Type of outcome Conference abstract
Field of Study 30205 Hematology
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
WWW URL
RIV identification code RIV/00216224:14110/23:00131269
Organization unit Faculty of Medicine
Keywords in English AML engraftment; humanized ossicles
Tags NÚVR_CEITEC, rivok
Tags International impact
Changed by Changed by: Mgr. Eva Dubská, učo 77638. Changed: 25/3/2024 13:55.
Abstract
AML engraftment in humanized ossicles is not governed by biomaterial selection - conference abstract.
Links
LX22NPO5102, research and development projectName: Národní ústav pro výzkum rakoviny (Acronym: NÚVR)
Investor: Ministry of Education, Youth and Sports of the CR, National institute for cancer research, 5.1 EXCELES
MUNI/A/1224/2022, interní kód MUName: Nové přístupy ve výzkumu, diagnostice a terapii hematologických malignit X
Investor: Masaryk University
PrintDisplayed: 10/7/2024 20:38